|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.42 USD | +2.88% |
|
+4.18% | +11.17% |
| Capitalization | 5.62B 4.74B 4.32B 4.13B 7.66B 509B 7.96B 50.26B 19.95B 246B 21.08B 20.65B 859B | P/E ratio 2025 * |
27.7x | P/E ratio 2026 * | 23.9x |
|---|---|---|---|---|---|
| Enterprise value | 6.37B 5.37B 4.9B 4.68B 8.68B 577B 9.02B 56.96B 22.61B 279B 23.9B 23.41B 974B | EV / Sales 2025 * |
1.13x | EV / Sales 2026 * | 1.03x |
| Free-Float |
92.06% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Option Care Health, Inc.
| 1 day | +2.88% | ||
| 1 week | +4.18% | ||
| Current month | +4.18% | ||
| 1 month | -1.91% | ||
| 3 months | +24.67% | ||
| 6 months | +25.07% | ||
| Current year | +11.17% |
| 1 week | 33 |  | 35.46 |
| 1 month | 33 | | 36.8 |
| Current year | 30.86 | | 36.8 |
| 1 year | 24.24 | | 36.8 |
| 3 years | 21.39 | | 36.8 |
| 5 years | 16.02 | | 36.8 |
| 10 years | 5.74 | | 36.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 59 | 05/08/2019 |
Meenal Sethna
DFI | Director of Finance/CFO | 57 | 30/09/2025 |
Femi Adewunmi
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Rademacher
BRD | Director/Board Member | 59 | 05/08/2019 |
Timothy Sullivan
BRD | Director/Board Member | 68 | 06/08/2019 |
Elizabeth Betten
BRD | Director/Board Member | 45 | 06/08/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.88% | +4.18% | +12.59% | +21.72% | 5.62B | |
| +0.95% | +7.69% | +70.86% | +108.57% | 121B | |
| +0.71% | +0.17% | +19.22% | -11.17% | 99.84B | |
| +0.56% | +1.81% | +35.96% | +79.01% | 33.86B | |
| +0.39% | +1.88% | -12.70% | +11.98% | 24.25B | |
| +1.63% | +1.96% | +14.66% | +13.85% | 23.43B | |
| +0.00% | +8.47% | +22.58% | +41.09% | 22.76B | |
| -0.50% | +14.76% | +73.36% | +274.49% | 20.31B | |
| +0.61% | +2.72% | +44.76% | +57.07% | 18B | |
| +0.32% | +7.44% | +29.34% | +58.51% | 14.67B | |
| Average | +0.76% | +5.01% | +31.06% | +65.51% | 38.35B | |
| Weighted average by Cap. | +0.71% | +4.57% | +39.22% | +62.07% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.65B 4.76B 4.34B 4.14B 7.69B 512B 7.99B 50.49B 20.04B 247B 21.18B 20.75B 863B | 5.98B 5.04B 4.6B 4.39B 8.15B 542B 8.47B 53.49B 21.23B 262B 22.44B 21.98B 915B |
| Net income | 209M 176M 161M 153M 285M 18.93B 296M 1.87B 742M 9.14B 784M 768M 31.95B | 236M 199M 181M 173M 321M 21.38B 334M 2.11B 838M 10.32B 885M 867M 36.08B |
| Net Debt | 750M 632M 577M 550M 1.02B 67.94B 1.06B 6.71B 2.66B 32.81B 2.81B 2.76B 115B | 560M 472M 431M 411M 763M 50.75B 793M 5.01B 1.99B 24.51B 2.1B 2.06B 85.65B |
Employees
7,052
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 35.42 $ | +2.88% | 1,100,324 |
| 12/02/26 | 34.43 $ | -0.69% | 2,285,984 |
| 11/02/26 | 34.67 $ | +4.59% | 2,301,001 |
| 10/02/26 | 33.15 $ | -0.06% | 1,722,459 |
| 09/02/26 | 33.17 $ | -2.44% | 1,271,201 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
35.42USD
Average target price
39.82USD
Spread / Average Target
+12.42%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OPCH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition